Cytotoxicity of a series of ferrocene-containing β-diketones

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2781-2784

  Swarts, Jannie C ^a   Vosloo, Theunis G ^a   Cronje, Sarina J ^a   Du Plessis, W C ^a   Van Rensburg, Constance E J ^b   Kreft, Elke ^b   Van Lier, Johan E ^c  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

CoLo 320DM; CORL23 CPR; Cytotoxicity; Ferrocene; Diketone

Indexed keywords

1,3 DIKETONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CISPLATIN; FERROCENE;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; HELA CELL; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL;

EID: 55749096921     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Drobnik J and Horacek P: Specific biological activity of platinum complexes. Theory of molecular mechanism. Chem Biol Interac I 7: 223-229, 1973.
2. Burchenal JH, Kalaher K, O'Toole T and Chrisholm J: Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia. Cancer Res 37: 3455-3457, 1977.
3. Wolf W and Manaka RC: Synthesis and distribution of platinum-195m- labelled cis-dichlorodiammine platinum(II). J Clin Hemotol Oncol 7: 79-95, 1977.
4. Rozencweig M, Van Hoff DD, Slavik M and Chrisholm J: Cis-diamminedichloroplatinum(II). A new anticancer drug. Ann Intern Med 86: 803-812, 1977.
5. Duncan R and Kopecek J: Soluble synthetic polymers potential drug carriers. Adv Polym Sci 57: 51-102, 1984.
6. Gale GR, Atins LM, Meischen SJ, Smith AB and Walker EM: Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents. Cancer Treat Rep 61: 445-450, 1977.
7. Ringsdorf: Structure and properties of pharmacologically active polymers. J Polym Sci Pol Symp 51: 135-153, 1976.
8. Swarts JC, Swarts DM, Maree DM, Neuse EW, La Madeleine C and Van Lier J: Poly aspartamides as water-soluble drug carriers Part 1: Antineoplastic activity of ferrocene-containing polyaspartamide conjugates. Anticancer Res 21: 2033-3037, 2001.
9. Sharman WM, Allen CM and Van Lier JE: Photodynamic therapeutics: basic principles and clinical applications. Drug Discov Today 44: 507-517, 1999.
10. Köpf-Maier P, Köpf H and Neuse EW: Ferricenium complexes: a new type of water-soluble antitumor agent. J Cancer Res Clin Oncol 108: 336-340, 1984.
11. Ward JM, Grabin ME, Berlin E and Young DM: Prevention of renal failure in rats receiving cis-diamminedichloroplatinum(II) by administration of furosemide. Cancer Res 37: 1238-1240, 1977.
12. Neuse EW and Kanzawa F: Evaluation of the activity of some water-soluble ferrocene and ferricenium compounds against carcinoma of the lung by the human tumor clonogenic assay. Appl Organomet Chem 4: 19-26, 1990.
13. Osella D, Ferrali M, Zanello P, Laschi F, Fontani M, Nervi C and Carvigiolio G: On the mechanism of the anti-tumour activity of ferrocenium derivatives. Inorg Chim Acta 306: 42-48, 2000.
14. Epton R, Hobson ME and Marr G: Oxidation of ferrocene and substituted ferrocenes in the presence of horseradish peroxidase. J Organomet Chem 149: 231-244, 1978.
15. Pladziewicz JR and Carney MJ: Reduction of ferricenium ion by horse heart ferrocytochrome-C. J Am Chem Soc 104: 3544-3545, 1982.
16. Carlson BW, Grodkowski J, Miller LL and Neta P: Oxidation of NADH involving rate-limiting one-electron transfer. J Am Chem Soc 106: 7233-7239, 1984.
17. Pladziewicz JR, Rodeberg DA, Likar MD and Brenner MS: Kinetic study of the oxidation of spinach plastocyanine by ferrocenium ion derivatives. Inorg Chem 24: 1450-1453, 1985.
18. Pladziewicz JR, Abrahamson AJ, Davis RA and Likar MD: Kinetics of the oxidation of high-potential iron sulfur protein from chromatium by ferrocenium derivatives. Inorg Chem 26: 2058-2062, 1987.
19. Shago RF, Swarts JC, Kreft E and Van Rensburg CEJ: Antineoplastic activity of a series of ferrocene-containing alcohols. Anticancer Res 27: 3431-3434, 2007.
20. Du Plessis WC, Erasmus JJC, Lamprecht GJ, Conradie J, Cameron ST, Aquino MAS and Swarts JC: Cyclic voltammetry of ferrocene-containing β-diketones as a tool to obtain group electronegativities. The structure of 3-ferrocenoyl-1,1,1-trifluoro-2-hydroxyprop-2-ene. Can J Chem 77: 378-386, 1999.
21. Du Plessis WC, Vosloo TG and Swarts JC: β-Diketones containing a ferrocenyl group: synthesis, structural aspects, pKá values, group electronegativities and complexation with rhodium(I). J Chem Soc, Dalton Trans: pp. 2507-2514, 1998.
22. Paquette B, Boyle RW, Ali H, MacLennan AH, Truscott TG and Van Lier JE: Sulfonated phthalimidomethyl aluminum pthalocyanine: the effect of hydrophobic substituents on the in vitro phototoxicity of phthalocyanines. Photochem Photobiol 53: 323-327, 1991.
23. Van Rensburg CEJ, Jooné GK and O'Sullivan JF: Tetramethylpiperidine-substitution increases the antitumor activity of the aminophenazines for an acquired multidrug-resistant cell line. Anticancer Drug Design 15: 303-306, 2000.
24. 2. Eur J Inorg Chem: p. 313, 1999.